143 related articles for article (PubMed ID: 16239591)
1. HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.
van Wanrooij EJ; Happé H; Hauer AD; de Vos P; Imanishi T; Fujiwara H; van Berkel TJ; Kuiper J
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2642-7. PubMed ID: 16239591
[TBL] [Abstract][Full Text] [Related]
2. The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis.
Tokuyama H; Ueha S; Kurachi M; Matsushima K; Moriyasu F; Blumberg RS; Kakimi K
Int Immunol; 2005 Aug; 17(8):1023-34. PubMed ID: 16000328
[TBL] [Abstract][Full Text] [Related]
3. A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.
Uekusa Y; Yu WG; Mukai T; Gao P; Yamaguchi N; Murai M; Matsushima K; Obika S; Imanishi T; Higashibata Y; Nomura S; Kitamura Y; Fujiwara H; Hamaoka T
Cancer Res; 2002 Jul; 62(13):3751-8. PubMed ID: 12097285
[TBL] [Abstract][Full Text] [Related]
4. TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans.
Baba M; Takashima K; Miyake H; Kanzaki N; Teshima K; Wang X; Shiraishi M; Iizawa Y
Antimicrob Agents Chemother; 2005 Nov; 49(11):4584-91. PubMed ID: 16251299
[TBL] [Abstract][Full Text] [Related]
5. CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice.
van Wanrooij EJ; de Jager SC; van Es T; de Vos P; Birch HL; Owen DA; Watson RJ; Biessen EA; Chapman GA; van Berkel TJ; Kuiper J
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):251-7. PubMed ID: 18048768
[TBL] [Abstract][Full Text] [Related]
6. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
Nofer JR; Bot M; Brodde M; Taylor PJ; Salm P; Brinkmann V; van Berkel T; Assmann G; Biessen EA
Circulation; 2007 Jan; 115(4):501-8. PubMed ID: 17242282
[TBL] [Abstract][Full Text] [Related]
7. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo.
Veillard NR; Steffens S; Pelli G; Lu B; Kwak BR; Gerard C; Charo IF; Mach F
Circulation; 2005 Aug; 112(6):870-8. PubMed ID: 16061736
[TBL] [Abstract][Full Text] [Related]
8. Effects of blocking the chemokine receptors, CCR5 and CXCR3, With TAK-779 in a rat small intestinal transplantation model.
Xu H; Firdawes S; Yamamoto A; Zhao Y; Ihara Y; Uehara S; Matsunami K; Otsuka H; Fukuzawa M; Miyagawa S
Transplantation; 2008 Dec; 86(12):1810-7. PubMed ID: 19104427
[TBL] [Abstract][Full Text] [Related]
9. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
Potteaux S; Combadière C; Esposito B; Lecureuil C; Ait-Oufella H; Merval R; Ardouin P; Tedgui A; Mallat Z
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1858-63. PubMed ID: 16763157
[TBL] [Abstract][Full Text] [Related]
10. Effects of a calcineurin inhibitor, FK506, and a CCR5/CXCR3 antagonist, TAK-779, in a rat small intestinal transplantation model.
Takama Y; Miyagawa S; Yamamoto A; Firdawes S; Ueno T; Ihara Y; Kondo A; Matsunami K; Otsuka H; Fukuzawa M
Transpl Immunol; 2011 Jul; 25(1):49-55. PubMed ID: 21515370
[TBL] [Abstract][Full Text] [Related]
11. The blocking of CXCR3 and CCR5 suppresses the infiltration of T lymphocytes in rat renal ischemia reperfusion.
Tsutahara K; Okumi M; Kakuta Y; Abe T; Yazawa K; Miyagawa S; Matsunami K; Otsuka H; Kaimori J; Takahara S; Nonomura N
Nephrol Dial Transplant; 2012 Oct; 27(10):3799-806. PubMed ID: 22904101
[TBL] [Abstract][Full Text] [Related]
12. Blocking of CCR5 and CXCR3 suppresses the infiltration of macrophages in acute renal allograft rejection.
Kakuta Y; Okumi M; Miyagawa S; Tsutahara K; Abe T; Yazawa K; Matsunami K; Otsuka H; Takahara S; Nonomura N
Transplantation; 2012 Jan; 93(1):24-31. PubMed ID: 22124337
[TBL] [Abstract][Full Text] [Related]
13. Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine.
Kang SG; Piniecki RJ; Hogenesch H; Lim HW; Wiebke E; Braun SE; Matsumoto S; Kim CH
Gastroenterology; 2007 Mar; 132(3):966-81. PubMed ID: 17324406
[TBL] [Abstract][Full Text] [Related]
14. FcgammaRIIB inhibits the development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
Zhao M; Wigren M; Dunér P; Kolbus D; Olofsson KE; Björkbacka H; Nilsson J; Fredrikson GN
J Immunol; 2010 Mar; 184(5):2253-60. PubMed ID: 20097865
[TBL] [Abstract][Full Text] [Related]
15. Blockade of Th1 chemokine receptors ameliorates pulmonary granulomatosis in mice.
Kishi J; Nishioka Y; Kuwahara T; Kakiuchi S; Azuma M; Aono Y; Makino H; Kinoshita K; Kishi M; Batmunkh R; Uehara H; Izumi K; Sone S
Eur Respir J; 2011 Aug; 38(2):415-24. PubMed ID: 21273392
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1.
Heredia A; Amoroso A; Davis C; Le N; Reardon E; Dominique JK; Klingebiel E; Gallo RC; Redfield RR
Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10411-6. PubMed ID: 12915736
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice.
Veillard NR; Kwak B; Pelli G; Mulhaupt F; James RW; Proudfoot AE; Mach F
Circ Res; 2004 Feb; 94(2):253-61. PubMed ID: 14656931
[TBL] [Abstract][Full Text] [Related]
18. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
Xanthoulea S; Gijbels MJ; van der Made I; Mujcic H; Thelen M; Vergouwe MN; Ambagts MH; Hofker MH; de Winther MP
Cardiovasc Res; 2008 Nov; 80(2):309-18. PubMed ID: 18628255
[TBL] [Abstract][Full Text] [Related]
19. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells.
Heller EA; Liu E; Tager AM; Yuan Q; Lin AY; Ahluwalia N; Jones K; Koehn SL; Lok VM; Aikawa E; Moore KJ; Luster AD; Gerszten RE
Circulation; 2006 May; 113(19):2301-12. PubMed ID: 16682613
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of nondiabetic low-density lipoprotein receptor-null mice.
Thorp E; Kuriakose G; Shah YM; Gonzalez FJ; Tabas I
Circulation; 2007 Nov; 116(19):2182-90. PubMed ID: 17967777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]